Abstract

Abstract: The aim of this study is to conduct an extensive literature review on recent advancements in the treatment of human immunodeficiency virus (HIV). This is because in extant studies, the care of the HIV infected patient has changed dramatically in the last few years. Potent new antiretroviral drugs combined with updated treatment strategies have now achieved efficient inhibition of HIV replication in most patients. Classes of drugs include both nucleoside and non-nucleoside inhibitors of the viral enzyme reverse transcriptase (RT) and inhibitors of the viral protease and integrase enzymes. The methodology used in this study was reviewed from secondary sources of information including journals, articles, newspaper, and textbooks. In this study, authors found that a major drawback of the highly active antiretroviral therapy (HAART) is the selection of resistant mutants under suboptimal dosage, in advanced stages of disease or after pre-treatment with mono- or double-combination regimens. In addition, monitoring of antiretroviral therapy is achieved by measurement of viral load using nucleic acid amplification techniques. Strict adherence to HIV drug regimens was reported to be essential for reaching and maintaining therapeutic levels of anti-retro-virals and avoiding development of drug-resistant HIV strains. This strict dosage-taking adherence makes HIV therapies among the most challenging treatments with which to adhere. Future researchers are encouraged to adopt a scientific approach in investigating the various constructs that have emerged in this study in other to provide more generalized findings for the research community and public policy makers. Keywords: Antiretroviral Drugs: Combination Therapy: Medication: Transmission: Inhibitors: Immune System.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call